Details of the Drug

General Information of Drug (ID: DM1TL3W)

• Drug Name: BNT221
• Synonyms: NEO-PTC-01

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DG97OH

References

• [1] ClinicalTrials.gov (NCT04625205) An Open-label, Phase I Study of NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma. U.S.National Institutes of Health.